Rubinstein Linda M 4
4 · Adverum Biotechnologies, Inc. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-02-12+350,000→ 350,000 totalExercise: $1.99Exp: 2034-02-11→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option shall vest and become exercisable on the first anniversary of February 12, 2024 (the "Vesting Commencement Date"), and one-forty-eighth (1/48th) of the total number of shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable on the fourth (4th) anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.